Publication

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.

Journal Paper/Review - Feb 11, 2023

Units
PubMed
Doi
Contact

Citation
Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.
Type
Journal Paper/Review (English)
Journal
Obes Surg 2023
Publication Date
Feb 11, 2023
Issn Electronic
1708-0428
Pages
1-9
Brief description/objective

Weight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) for treatment of type 2 diabetes mellitus and obesity is well established, but their role in the treatment of weight regain after bariatric surgery remains to be defined.